Discrepancies in Dapagliflozin Response in Terms of Glycemic Control and Body Weight Reduction
A short duration of diabetes and early response to treatment appear to represent key factors in maximizing the benefits of dapagliflozin for blood glucose and weight management.
Authors
- Nan Hee Kim (ORCID: https://orcid.org/0000-0003-4378-520X)
- In‐Kyung Jeong (ORCID: https://orcid.org/0000-0001-7857-546X)
- Ji Eun Jun (ORCID: https://orcid.org/0000-0002-7204-4913)
- Kwan Woo Lee (ORCID: https://orcid.org/0000-0002-7965-9662)
- Kyoung‐Ah Kim (ORCID: https://orcid.org/0000-0001-5629-830X)
Institutions
- Korea University (KR)
- Ajou University Hospital (KR)
- Dongguk University Ilsan Hospital (KR)
- Kyung Hee University Hospital at Gangdong (KR)
Publication Details
- Journal
- Endocrinology and Metabolism
- Published
- 2025-03-19
- DOI
- https://doi.org/10.3803/enm.2024.2142
- Citations
- 3
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 3.88